Joel Howard Rubenstein MD

Assistant Professor, Internal Medicine
Gastroenterology, Internal Medicine
Clinical Interests:

achalasia, Barrett's esophagus, difficulty swallowing, dysplasia, eosinophilic esophagitis, esophageal cancer

Video profile


U of M Gastroenterology

Taubman Center, Floor 3, Reception D
1500 E Medical Center Dr
Ann Arbor

U of M Gastroenterology - Medical Procedures

East Ann Arbor Ambulatory Surgery and Medical Procedures Center
4270 Plymouth Rd
Ann Arbor


Medical School or Training

  • Washington University School of Medicine, 1998


  • University of Chicago Pritzker School of Medicine, Internal Medicine, IL, 2001


  • Internal Medicine Gastroenterology, University of Michigan Health System, 2004

Professional Organizations

  • Fellow, American College of Gastroenterology

  • Fellow, American Gastroenterology Association

  • Fellow, American Society for Gastrointestinal Endoscopy

  • Member, American College of Physicians

Board Certification

  • Gastroenterology


Clinical and translational research in developing effective strategies of identifying Barrett's esophagus and preventing death from esophageal cancer. 


Joel Rubenstein, M.D., M.Sc. is Director of the Barrett's Esophagus Program and Assistant Professor in the Division of Gastroenterology at the University of Michigan, and is a Research Scientist at the Veterans Affairs Center of Excellence for Clinical Management Research.

Dr. Rubenstein earned a Bachelors of Science from the University of Michigan, majoring in biophysics. He then earned his medical degree from Washington University in St. Louis. After completing his residency training in internal medicine at the University of Chicago, Dr. Rubenstein returned to the University of Michigan, where he completed fellowship training in gastroenterology, earned a Masters of Science in Clinical Research Design and Statistical Analysis, and then joined the faculty of the Division of Gastroenterology in 2004.

Dr. Rubenstein is a recognized expert in the diagnosis and management of Barrett's esophagus, a precancerous lesion associated with esophageal cancer. His research aims to develop efficient management strategies for identifying Barrett's esophagus and preventing death from esophageal cancer. Dr. Rubenstein's research has been supported by the National Institutes of Health, the Department of Veterans Affairs, the Damon Runyon Cancer Research Foundation, and other sources.

In addition to Barrett's esophagus, Dr. Rubenstein has clinical expertise in other esophageal disoders, including achalasia and eosinophilic esophagitis.

Dr. Rubenstein is the Vice Chair of the Clinical Practice Section of the American Gastroenterology Association. He serves as a Special Sections Editor for the journal, Gastroenterology, and serves on the Editorial Advisory Board of the American Journal of Gastroenterology.